Stockreport

Jaguar Health and its Subsidiary, Napo Pharmaceuticals, Enter into Fifth Amendment to the Accounts Receivable Purchase Agreement with Oasis Capital, LLC, Dated May 12, 2020

Jaguar Health, Inc.  (JAGX) 
US:NASDAQ Investor Relations: jaguarhealth.gcs-web.com/investor-overview
PDF The Sixth Tranche Accounts Receivable has a gross value of $3,810,587.04, representing customer billings over a 51-day periodSAN FRANCISCO, CA / ACCESSWIRE / December 4, [Read more]